178 related articles for article (PubMed ID: 11004527)
1. Thioxo amino acid pyrrolidides and thiazolidides: new inhibitors of proline specific peptidases.
Stöckel-Maschek A; Mrestani-Klaus C; Stiebitz B; Demuth H; Neubert K
Biochim Biophys Acta; 2000 Jun; 1479(1-2):15-31. PubMed ID: 11004527
[TBL] [Abstract][Full Text] [Related]
2. Substrates containing phosphorylated residues adjacent to proline decrease the cleavage by proline-specific peptidases.
Kaspari A; Diefenthal T; Grosche G; Schierhorn A; Demuth HU
Biochim Biophys Acta; 1996 Mar; 1293(1):147-53. PubMed ID: 8652620
[TBL] [Abstract][Full Text] [Related]
3. Potent inhibitors of dipeptidyl peptidase IV and their mechanisms of inhibition.
Stöckel-Maschek A; Stiebitz B; Born I; Faust J; Mögelin W; Neubert K
Adv Exp Med Biol; 2000; 477():117-23. PubMed ID: 10849737
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function.
Flentke GR; Munoz E; Huber BT; Plaut AG; Kettner CA; Bachovchin WW
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1556-9. PubMed ID: 1671716
[TBL] [Abstract][Full Text] [Related]
5. Influence on proline-specific enzymes of a substrate containing the thioxoaminoacyl-prolyl peptide bond.
Schutkowski M; Neubert K; Fischer G
Eur J Biochem; 1994 Apr; 221(1):455-61. PubMed ID: 7909521
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of peptidyl-prolyl cis/trans isomerase activity by substrate analog structures: thioxo tetrapeptide-4-nitroanilides.
Schutkowski M; Wöllner S; Fischer G
Biochemistry; 1995 Oct; 34(40):13016-26. PubMed ID: 7548060
[TBL] [Abstract][Full Text] [Related]
7. Novel 3-amino-2-hydroxy acids containing protease inhibitors. Part 1: Synthesis and kinetic characterization as aminopeptidase P inhibitors.
Stöckel-Maschek A; Stiebitz B; Koelsch R; Neubert K
Bioorg Med Chem; 2005 Aug; 13(16):4806-20. PubMed ID: 15993089
[TBL] [Abstract][Full Text] [Related]
8. Purification of two dipeptidyl aminopeptidases II from rat brain and their action on proline-containing neuropeptides.
Mentlein R; Struckhoff G
J Neurochem; 1989 Apr; 52(4):1284-93. PubMed ID: 2564425
[TBL] [Abstract][Full Text] [Related]
9. Post-proline-cleaving peptidases having DP IV like enzyme activity. Post-proline peptidases.
Abbott CA; Yu D; McCaughan GW; Gorrell MD
Adv Exp Med Biol; 2000; 477():103-9. PubMed ID: 10849735
[TBL] [Abstract][Full Text] [Related]
10. Dipeptidyl peptidase IV in the immune system. Effects of specific enzyme inhibitors on activity of dipeptidyl peptidase IV and proliferation of human lymphocytes.
Schön E; Born I; Demuth HU; Faust J; Neubert K; Steinmetzer T; Barth A; Ansorge S
Biol Chem Hoppe Seyler; 1991 May; 372(5):305-11. PubMed ID: 1678607
[TBL] [Abstract][Full Text] [Related]
11. Design of (omega-N-(O-acyl)hydroxy amid) aminodicarboxylic acid pyrrolidides as potent inhibitors of proline-specific peptidases.
Demuth HU; Schlenzig D; Schierhorn A; Grosche G; Chapot-Chartier MP; Gripon JC
FEBS Lett; 1993 Mar; 320(1):23-7. PubMed ID: 8096464
[TBL] [Abstract][Full Text] [Related]
12. Probing substrate backbone function in prolyl oligopeptidase catalysis--large positional effects of peptide bond monothioxylation.
Schutkowski M; Jakob M; Landgraf G; Born I; Neubert K; Fischer G
Eur J Biochem; 1997 Apr; 245(2):381-5. PubMed ID: 9151967
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of proline-specific proteinases: (I) Substrate specificity of dipeptidyl peptidase IV from pig kidney and proline-specific endopeptidase from Flavobacterium meningosepticum.
Heins J; Welker P; Schönlein C; Born I; Hartrodt B; Neubert K; Tsuru D; Barth A
Biochim Biophys Acta; 1988 May; 954(2):161-9. PubMed ID: 2896517
[TBL] [Abstract][Full Text] [Related]
14. Peptidyl ammonium methyl ketones as substrate analog inhibitors of proline-specific peptidases.
Steinmetzer T; Silberring J; Mrestani-Klaus C; Fittkau S; Barth A; Demuth HU
J Enzyme Inhib; 1993; 7(2):77-85. PubMed ID: 7509871
[TBL] [Abstract][Full Text] [Related]
15. A new type of fluorogenic substrates for determination of cellular dipeptidyl peptidase IV (DP IV/CD26) activity.
Lorey S; Faust J; Bühling F; Ansorge S; Neubert K
Adv Exp Med Biol; 2000; 477():111-5. PubMed ID: 10849736
[TBL] [Abstract][Full Text] [Related]
16. Development of highly potent and selective phosphinic peptide inhibitors of zinc endopeptidase 24-15 using combinatorial chemistry.
Jirácek J; Yiotakis A; Vincent B; Lecoq A; Nicolaou A; Checler F; Dive V
J Biol Chem; 1995 Sep; 270(37):21701-6. PubMed ID: 7665587
[TBL] [Abstract][Full Text] [Related]
17. DPP4 inhibitors increase differentially the expression of surfactant proteins in Fischer 344 rats.
Schmiedl A; Grützner D; Hoffmann T; von Hörsten S; Stephan M
Acta Physiol (Oxf); 2014 Nov; 212(3):248-61. PubMed ID: 25069535
[TBL] [Abstract][Full Text] [Related]
18. Type 2 diabetes--therapy with dipeptidyl peptidase IV inhibitors.
Demuth HU; McIntosh CH; Pederson RA
Biochim Biophys Acta; 2005 Aug; 1751(1):33-44. PubMed ID: 15978877
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl peptidases 8 and 9: specificity and molecular characterization compared with dipeptidyl peptidase IV.
Bjelke JR; Christensen J; Nielsen PF; Branner S; Kanstrup AB; Wagtmann N; Rasmussen HB
Biochem J; 2006 Jun; 396(2):391-9. PubMed ID: 16475979
[TBL] [Abstract][Full Text] [Related]
20. The therapeutic potential of inhibitors of dipeptidyl peptidase IV (DPP IV) and related proline-specific dipeptidyl aminopeptidases.
Augustyns K; Van der Veken P; Senten K; Haemers A
Curr Med Chem; 2005; 12(8):971-98. PubMed ID: 15853709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
